An open-label study of the therapeutic efficacy of high-dose famotidine adjuvant pharmacotherapy in schizophrenia: preliminary evidence for treatment efficacy. - Rosse RB; Kendrick K; Fay-McCarthy M; Prell GD; Rosenberg P; Tsui LC; Wyatt RJ; Deutsch SI (Clinical neuropharmacology, 1996)